HomeThrombolex Inc.

Thrombolex Inc.

Bashir® Endovascular Catheter First-In-Human Trial for Acute Pulmonary Embolism Confirms Early Safety and Feasibility and Impressive Reduction of Clot Burden

The data showed a significant reduction in right ventricular to left ventricular (RV/LV) diameter ratio and clot burden. Results of the FIH Trial were presented at the American Venous Forum Annual Meeting